This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction. Assessing Antidepressant Efficacy: A Reexamination

Dwight L. Evans, MD

Published: April 1, 1999

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

While treatment outcome has improved in patients with depressive and anxiety disorders since the introduction of the newer antidepressants including the selective serotonin reuptake inhibitors (SSRIs) and the serotonin-norepinephrine reuptake inhibitors (SNRIs), some special populations and those with specific subtypes of depression often remain treatment refractory. Also, some patients respond partially and continue to experience symptoms of depression. The purpose of this Supplement is to reexamine the issue of efficacy and completeness of response to antidepressant treatment.’ ‹

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 60

Quick Links: